BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

253 related articles for article (PubMed ID: 25748296)

  • 21. Conversion of mild cognitive impairment to dementia in elderly subjects: a preliminary study in a memory and cognitive disorder unit.
    Maioli F; Coveri M; Pagni P; Chiandetti C; Marchetti C; Ciarrocchi R; Ruggero C; Nativio V; Onesti A; D'Anastasio C; Pedone V
    Arch Gerontol Geriatr; 2007; 44 Suppl 1():233-41. PubMed ID: 17317458
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between EEG abnormalities and CSF biomarkers in a memory clinic cohort.
    Kramberger MG; Kåreholt I; Andersson T; Winblad B; Eriksdotter M; Jelic V
    Dement Geriatr Cogn Disord; 2013; 36(5-6):319-28. PubMed ID: 24022277
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cerebrospinal fluid biomarkers mirror rate of cognitive decline.
    Rolstad S; Berg AI; Bjerke M; Johansson B; Zetterberg H; Wallin A
    J Alzheimers Dis; 2013; 34(4):949-56. PubMed ID: 23313924
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term effects of amyloid, hypometabolism, and atrophy on neuropsychological functions.
    Ossenkoppele R; van der Flier WM; Verfaillie SC; Vrenken H; Versteeg A; van Schijndel RA; Sikkes SA; Twisk J; Adriaanse SM; Zwan MD; Boellaard R; Windhorst AD; Barkhof F; Scheltens P; Lammertsma AA; van Berckel BN
    Neurology; 2014 May; 82(20):1768-75. PubMed ID: 24748672
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Subjective cognitive complaints included in diagnostic evaluation of dementia helps accurate diagnosis in a mixed memory clinic cohort.
    Salem LC; Vogel A; Ebstrup J; Linneberg A; Waldemar G
    Int J Geriatr Psychiatry; 2015 Dec; 30(12):1177-85. PubMed ID: 25892198
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Conversion of amnestic Mild Cognitive Impairment to dementia of Alzheimer type is independent to memory deterioration.
    Rozzini L; Chilovi BV; Conti M; Bertoletti E; Delrio I; Trabucchi M; Padovani A
    Int J Geriatr Psychiatry; 2007 Dec; 22(12):1217-22. PubMed ID: 17562522
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of Worsened Metabolic Syndrome on the Risk of Dementia: A Nationwide Cohort Study.
    Fan YC; Chou CC; You SL; Sun CA; Chen CJ; Bai CH
    J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28899896
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neurogranin as a Cerebrospinal Fluid Biomarker for Synaptic Loss in Symptomatic Alzheimer Disease.
    Kester MI; Teunissen CE; Crimmins DL; Herries EM; Ladenson JH; Scheltens P; van der Flier WM; Morris JC; Holtzman DM; Fagan AM
    JAMA Neurol; 2015 Nov; 72(11):1275-80. PubMed ID: 26366630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. T-Tau is Associated with Objective Memory Decline Over Two Years in Persons Seeking Help for Subjective Cognitive Decline: A Report from the Gothenburg-Oslo MCI Study.
    Hessen E; Nordlund A; Stålhammar J; Eckerström M; Bjerke M; Eckerström C; Göthlin M; Fladby T; Reinvang I; Wallin A
    J Alzheimers Dis; 2015; 47(3):619-28. PubMed ID: 26401697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The clinical characteristics of 2,789 consecutive patients in a memory clinic in China.
    Wang B; Guo QH; Chen MR; Zhao QH; Zhou Y; Hong Z
    J Clin Neurosci; 2011 Nov; 18(11):1473-7. PubMed ID: 21924913
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Predicting Cognitive, Functional, and Diagnostic Change over 4 Years Using Baseline Subjective Cognitive Complaints in the Sydney Memory and Ageing Study.
    Slavin MJ; Sachdev PS; Kochan NA; Woolf C; Crawford JD; Giskes K; Reppermund S; Trollor JN; Draper B; Delbaere K; Brodaty H
    Am J Geriatr Psychiatry; 2015 Sep; 23(9):906-14. PubMed ID: 25441053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Latent Dementia Phenotype δ is Associated with Cerebrospinal Fluid Biomarkers of Alzheimer's Disease and Predicts Conversion to Dementia in Subjects with Mild Cognitive Impairment.
    Koppara A; Wolfsgruber S; Kleineidam L; Schmidtke K; Frölich L; Kurz A; Schulz S; Hampel H; Heuser I; Peters O; Reischies FM; Jahn H; Luckhaus C; Hüll M; Gertz HJ; Schröder J; Pantel J; Rienhoff O; Rüther E; Henn F; Wiltfang J; Maier W; Jessen F; Kornhuber J; Wagner M
    J Alzheimers Dis; 2016; 49(2):547-60. PubMed ID: 26484902
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Redefining Amnestic Mild Cognitive Impairment as an Early Form of Alzheimer's Disease Based on Assessment of Memory Systems.
    Bolívar JC; Saladie DG
    J Alzheimers Dis; 2016 May; 53(2):705-12. PubMed ID: 27163821
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Progression to dementia in memory clinic patients without dementia: a latent profile analysis.
    Köhler S; Hamel R; Sistermans N; Koene T; Pijnenburg YA; van der Flier WM; Scheltens P; Visser PJ; Aalten P; Verhey FR; Ramakers I
    Neurology; 2013 Oct; 81(15):1342-9. PubMed ID: 23997152
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mild cognitive impairments predict dementia in nondemented elderly patients with memory loss.
    Bozoki A; Giordani B; Heidebrink JL; Berent S; Foster NL
    Arch Neurol; 2001 Mar; 58(3):411-6. PubMed ID: 11255444
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Metabolic syndrome, mild cognitive impairment, and dementia.
    Panza F; Frisardi V; Seripa D; Imbimbo BP; Sancarlo D; D'Onofrio G; Addante F; Paris F; Pilotto A; Solfrizzi V
    Curr Alzheimer Res; 2011 Aug; 8(5):492-509. PubMed ID: 21605050
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Neuropsychological markers of dementia in patients with memory complaints.
    Guarch J; Marcos T; Salamero M; Blesa R
    Int J Geriatr Psychiatry; 2004 Apr; 19(4):352-8. PubMed ID: 15065228
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CSF biomarkers and medial temporal lobe atrophy predict dementia in mild cognitive impairment.
    Bouwman FH; Schoonenboom SN; van der Flier WM; van Elk EJ; Kok A; Barkhof F; Blankenstein MA; Scheltens P
    Neurobiol Aging; 2007 Jul; 28(7):1070-4. PubMed ID: 16782233
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The association of metabolic syndrome and cognitive impairment in Jidong of China: a cross-sectional study.
    Wang X; Ji L; Tang Z; Ding G; Chen X; Lv J; Chen Y; Li D
    BMC Endocr Disord; 2021 Mar; 21(1):40. PubMed ID: 33663435
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of CSF markers and semi-quantitative amyloid PET in Alzheimer's disease diagnosis and in cognitive impairment prognosis using the ADNI-2 database.
    Ben Bouallègue F; Mariano-Goulart D; Payoux P;
    Alzheimers Res Ther; 2017 Apr; 9(1):32. PubMed ID: 28441967
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.